11.22.19
EyeGate Pharma Hits Primary Endpoint in PRK Pivotal Study
WALTHAM, MA, November 22, 2019 (ACCESSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”), a clinical-stage company focused on developing products for treating disorders of the eye, announced...
Read more